home / stock / zom / zom news

ZOM News and Press, Zomedica Pharmaceuticals Corp. From 11/13/23

Stock Information
Company Name: Zomedica Pharmaceuticals Corp.
Stock Symbol: ZOM
Market: NYSE
Website: zomedica.com
Menu
ZOM ZOM Quote ZOM Short ZOM News ZOM Articles ZOM Message Board
Get ZOM Alerts

News, Short Squeeze, Breakout and More Instantly...
ZOM - Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the quarter ended Se...
ZOM - Notable earnings after Monday's close

2023-11-12 17:35:49 ET Major earnings expected after the bell on Monday include: Fisker ( FSR ) Star Bulk Carriers Corp. ( SBLK ) Gevo ( GEVO ) Danaos Corporation ( DAC ) Zomedica Corp. ( ZOM ) For further details see: Notable earnings aft...

ZOM - Earnings Week Ahead: Walmart, Home Depot, Target, Alibaba, Cisco and more

2023-11-12 08:19:00 ET Also reporting: SNDL FSR ZOM TSN CARA DAC SBLK OTCQB:CBWTF TSEM Also reporting: AAP CTLT CPA DAVA GLBE GFF HI JJSF JD MAXN PANW SQM SONO TJX XPEV Also reporting: ...

ZOM - Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / November 2, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Monday, November...
ZOM - Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference

ANN ARBOR, MI / ACCESSWIRE / October 12, 2023 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-...

ZOM - Zomedica buys Truforma platform developer Qorvo Biotech LLC

2023-10-05 08:08:31 ET More on Zomedica Financial information for Zomedica For further details see: Zomedica buys Truforma platform developer Qorvo Biotech LLC

ZOM - Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development

ANN ARBOR, MI / ACCESSWIRE / October 5, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic devices for companion animals, today announced the acquisition of Qorvo Biotechnologies LLC (QBT), creators of the Om...
ZOM - Zomedica, Inc. to Present at the LD Micro Main Event XVI

Presentation on Tuesday, October 3rd at 1:00 PM PT Ann Arbor, Michigan--(Newsfile Corp. - September 27, 2023) - Zomedica Corp. (NYSE American: ZOM) (the "Company") announced today that the Company is scheduled to provide a strategic overview and its prospects for growth during the LD Micro Main ...

ZOM - Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...

ZOM - Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing's Disease in Horses

ANN ARBOR, MI / ACCESSWIRE / September 14, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced the commercial launch of its newest assay - endogenous ACTH (eACTH...
Previous 10 Next 10